Back
Top 45%
15.1%
Top 0.2%
12.2%
Top 0.7%
9.3%
Top 24%
6.6%
Top 0.5%
6.6%
Top 0.5%
6.1%
Top 2%
5.2%
Top 62%
4.3%
Top 0.6%
4.0%
Top 11%
2.0%
Top 7%
1.6%
Top 0.7%
1.2%
Top 16%
1.0%
Top 2%
1.0%
Top 7%
1.0%
Top 2%
1.0%
Top 16%
1.0%
Top 44%
1.0%
Top 5%
0.7%
Top 64%
0.5%
Major Cardiovascular Event Risk of Advanced Therapies in Inflammatory Bowel Diseases: Systematic Review and Meta-Analysis
2026-01-29
gastroenterology
Title + abstract only
View on medRxiv
Show abstract
BackgroundPatients with chronic immune-mediated disorders (IMIDs), including inflammatory bowel disease (IBD), are at increased risk of cardiovascular disease. While advanced therapies show cardioprotective effects in other IMIDs, their impact on major adverse cardiovascular events (MACE) in IBD remains unclear. We conducted a meta-analysis of randomized controlled trials (RCTs) and observational studies evaluating MACE risk with advanced therapies in IBD. MethodsSystematic search of PubMed, Em...
Predicted journal destinations
1
PLOS ONE
1737 training papers
2
American Journal of Gastroenterology
15 training papers
3
Vaccines
131 training papers
4
BMJ Open
553 training papers
5
Frontiers in Medicine
99 training papers
6
Gut
17 training papers
7
Journal of Clinical Medicine
77 training papers
8
Scientific Reports
701 training papers
9
Gut Microbes
15 training papers
10
BMC Medicine
155 training papers
11
Frontiers in Immunology
140 training papers
12
Aging
18 training papers
13
PLOS Medicine
95 training papers
14
Frontiers in Pharmacology
27 training papers
15
Clinical Microbiology and Infection
54 training papers
16
Biomedicines
21 training papers
17
Cureus
64 training papers
18
eLife
262 training papers
19
Nutrients
43 training papers
20
Nature Communications
483 training papers